BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-6.35%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.4B
AUM Growth
+$11.4B
(-6.4%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
87.68%
Holding
125
New
6
Increased
22
Reduced
9
Closed
4
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$245M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$99.8M |
| 3 |
Ascendis Pharma
ASND
|
$11.1M |
| 4 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$10.3M |
| 5 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$5.96M |
Top Sells
| 1 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$69.3M |
| 2 |
DERM
Dermira, Inc.
DERM
|
$14.2M |
| 3 |
Exelixis
EXEL
|
$12.8M |
| 4 |
Neurocrine Biosciences
NBIX
|
$12.8M |
| 5 |
Cerus
CERS
|
$7.06M |
Sector Composition
| 1 | Healthcare | 92.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $4.3B | 37.57% | 34,130,161 +20,150 | +0.1% | +$2.54M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.37B | 20.68% | 45,725,556 +10,000 | +0% | +$517K |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.04B | 9.1% | 8,553,864 +2,009,734 | +31% | +$245M |
|
4
Acadia Pharmaceuticals
ACAD
$4.38B
| $720M | 6.3% | 25,819,768 | – | – |
|
|
5
BioMarin Pharmaceuticals
BMRN
$11.2B
| $536M | 4.69% | 5,905,673 +1,099,190 | +23% | +$99.8M |
|
|
GHDX
6
DELISTED
Genomic Health, Inc.
GHDX
| $449M | 3.92% | 13,779,866 +8,884 | +0.1% | +$289K |
|
|
DBVT
7
DBV Technologies
DBVT
$264M
| $197M | 1.72% | 5,509,560 | – | – |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $165M | 1.45% | 3,673,175 | – | – |
|
9
Neurogene
NGNE
$264M
| $154M | 1.35% | 10,934,154 | – | – |
|
|
AKAO
10
DELISTED
Achaogen, Inc.
AKAO
| $104M | 0.91% | 4,804,604 +222,222 | +5% | +$4.83M |
|
|
AMRN
11
Amarin Corp
AMRN
$311M
| $91.4M | 0.8% | 22,669,509 +13,040 | +0.1% | +$52.6K |
|
|
AAAP
12
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $86.7M | 0.76% | 2,221,706 | – | – |
|
|
ONCE
13
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $78.8M | 0.69% | 1,318,341 | – | – |
|
|
NVTA
14
DELISTED
Invitae Corporation
NVTA
| $69.7M | 0.61% | 7,288,300 | – | – |
|
15
BioCryst Pharmaceuticals
BCRX
$1.74B
| $65.1M | 0.57% | 11,716,784 | – | – |
|
|
BLCM
16
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $58.8M | 0.51% | 5,032,313 | – | – |
|
|
AVXS
17
DELISTED
AveXis, Inc. Common Stock
AVXS
| $51.4M | 0.45% | 625,000 +125,000 | +25% | +$10.3M |
|
|
18
Exelixis
EXEL
$10.1B
| $51.3M | 0.45% | 2,082,012 -521,557 | -20% | -$12.8M |
|
|
19
Ascendis Pharma
ASND
$11.8B
| $48.6M | 0.43% | 1,751,463 +400,000 | +30% | +$11.1M |
|
20
Heron Therapeutics
HRTX
$207M
| $38.6M | 0.34% | 2,783,569 | – | – |
|
21
Sangamo Therapeutics
SGMO
$157M
| $36.2M | 0.32% | 4,113,376 -417,525 | -9% | -$3.67M |
|
|
BLUE
22
DELISTED
bluebird bio
BLUE
| $31.7M | 0.28% | 301,441 -50,000 | -14% | -$5.25M |
|
|
ARAV
23
DELISTED
Aravive, Inc. Common Stock
ARAV
| $29M | 0.25% | 1,660,593 | – | – |
|
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $28.4M | 0.25% | 616,682 -278,740 | -31% | -$12.8M |
|
|
25
Cerus
CERS
$251M
| $25.7M | 0.22% | 10,241,943 -2,811,332 | -22% | -$7.06M |
|